Clinical Trial Update: Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study

View source ↗

Summary

This document describes a randomized controlled trial evaluating autologous cytokine-induced killer (CIK) cell infusion for lung cancer. The sponsor listed is T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Autologous CIK cell infusion (cytokine-induced killer (CIK) cells)

Snippet

Sponsor: Third Military Medical University | Conditions: Lung Cancer | Status: UNKNOWN